Tectonic Therapeutic (TECX) has had the best year this year by a US stock in the Nasdaq Composite (IXIC) this year, returning 6,012,400%.

ASSET	YEAR	% RETURN
Tectonic Therapeutic (TECX)	2024	6,012,400%
Iteris (ITI)	2024	5,230.81%
GeneDx (WGS)	2024	2,815.19%
Bright Minds Biosciences (DRUG)	2024	2,271.14%
Sezzle Inc Common Stock (SEZL)	2024	2,109.43%
LENZ Therapeutics (LENZ)	2024	1,927.07%
Fitell Corporation Ordinary Shares (FTEL)	2024	1,559.87%
Monopar Therapeutics (MNPR)	2024	1,114.5%
Dave (DAVE)	2024	958.4%
Root (ROOT)	2024	948.27%
Red Cat (RCAT)	2024	907.87%
Nano Nuclear Energy Inc Common Stock (NNE)	2024	833.33%
Nexalin Technology (NXL)	2024	811.69%
Dogness International Corp Class A (DOGZ)	2024	775.36%
Applovin (APP)	2024	745.75%
Eco Wave Power Global AB ADR (WAVE)	2024	688.28%
Kingstone Companies (KINS)	2024	669.04%
Summit Therapeutics (SMMT)	2024	636.43%
Quantum Computing (QUBT)	2024	556.41%
Exicure (XCUR)	2024	525.81%
Chanson International Holding Class A Ordinary Shares (CHSN)	2024	525%
Palladyne AI (PDYN)	2024	515.47%
MicroStrategy (MSTR)	2024	509.22%
Wang & Lee Group, Inc Ordinary Shares (WLGS)	2024	490.21%
Intuitive Machines (LUNR)	2024	474.9%